The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian


September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

Global surface guided radiation therapy (SGRT) devices market is projected to see an extraordinary growth in the forecast period, 2022-2026. The market growth can be attributed to the increasing instances of skin cancer. The advancing novel technology in radiotherapy for the cancer treatment is further substantiating the growth of the market. Moreover, increased adoption of radiotherapy devices and procedures along with the rising preference for the non-surgical procedures are further substantiating the growth of the global SGRT devices market in the upcoming five years.

In addition, the technological advancement in SGRT devices has advantages like patient positioning with real-time feedback, patient monitoring throughout the treatment fraction and motion management. More technical advancements including accelerated partial breast irradiation, particle radiotherapy, and pediatrics are also actively responsible for the growth of the global SGRT devices market in the next five years. However, the high cost of the therapy and the medical device may put a mild restraint on the global SGRT devices market growth in the future five years of forecast until 2026.

Surface guided radiation therapy devices are the medical radiation devices that are utilized for the SGRT. The technology positions and monitors the patient's surface radiation process on the external surface such that the patient's positioning is apt. This procedure provides transitional and rotational information of the patient's skin surface and offers the potential to improve the accuracy of setup. The global devices market segmentation is based on device type, application, end user, regional distribution, and competitional landscape. Based on device type, the market is divided between portable and fixed devices.

Fixed devices are anticipated to hold the largest revenue shares of the market and dominate the market segment on the account of increasing advancement in the healthcare industry dedicated toward oncological treatment and diagnostic processes. Portable devices are expected to register the fastest growing CAGR in the upcoming five years with its added advantage of mobility. These devices are more affordable, and can be installed in smaller healthcare centers, and clinics too, thereby supporting the growth of the global surface guided radiation therapy devices market in the next five years. Added advantages include emission of electrons, photons, and other fast-moving subatomic particles, and use of x-ray tubes to build contact between the device and the targeted area in patient's body.

Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through SGRT devices. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers and acquisitions and new product developments.

For more information: www.researchandmarkets.com/r/t666r5


Related Content

News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 09, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now